Dihydrofolate Reductase Inhibitor Antimalarial Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Dihydrofolate Reductase Inhibitor Antimalarial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Pharms | PYRIMETHAMINE | pyrimethamine | TABLET;ORAL | 215506-001 | Aug 13, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Sanaluz | PYRIMETHAMINE | pyrimethamine | TABLET;ORAL | 207127-001 | Feb 28, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Alvogen | PYRIMETHAMINE | pyrimethamine | TABLET;ORAL | 211271-001 | Jul 27, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Aurobindo Pharma Ltd | PYRIMETHAMINE | pyrimethamine | TABLET;ORAL | 216983-001 | Oct 25, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |